Skip to main content Accessibility help
×
Home

Gut Check: Clostridium difficile Testing and Treatment in the Molecular Testing Era

  • Whitney R. Buckel (a1), Edina Avdic (a2), Karen C. Carroll (a3) (a4), Vidhya Gunaseelan (a2), Eric Hadhazy (a3) and Sara E. Cosgrove (a3)...

Abstract

We evaluated the impact of nursing education and stewardship interventions on Clostridium difficile testing and treatment appropriateness. Diarrhea documentation increased for those with positive tests (45% to 70%); pretreatment laxative use decreased (50% to 19%). Appropriate treatment increased for severe infection (57% to 93%), but all asymptomatically colonized patients were treated.

Infect Control Hosp Epidemiol 2014;00(0): 1–5

Copyright

Corresponding author

Address correspondence to Whitney R. Buckel, PharmD, Intermountain Medical Center, 5121 South Cottonwood Street, Murray, UT 84107 (whitney.buckel@imail.org).

Footnotes

Hide All

Presented at IDWeek; San Diego, CA; October 19, 2012.

Footnotes

References

Hide All
1. Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 2013;56:6773.
2. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431455.
3. Sydnor, ER, Lenhart, A, Trollinger, B, et al. Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies. Infect Control Hosp Epidemiol 2011;32:11331136.
4. Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 2011;49:28872893.
5. Peterson, LR, Manson, RU, Paule, SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007;45:11521160.
6. Leekha, S, Aronhalt, KC, Sloan, LM, Patel, R, Orenstein, R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control 2013;41:390393.
7. Loo, VG, Bourgault, AM, Poirier, L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:16931703.
8. Alasmari, F, Seiler, SM, Hink, T, et al. Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis 2014;59:216222.
9. Johnson, S, Homann, SR, Bettin, KM, et al. Treatment of asymptomatic clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med 1992;117:297302.
10. Jardin, CG, Palmer, HR, Shah, DN, et al. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect 2013;85:2832.
Type Description Title
PDF
Supplementary materials

Buckel Supplementary Material
Supplementary Material

 PDF (105 KB)
105 KB

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed